Xiaobin Wu

CIK: 0001739452

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)66 (81.5%)

Position reduction

Option Exercises (M)10 (12.3%)

Derivative conversions

Awards (A)5 (6.2%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ONC

BeOne Medicines Ltd.

Officer

Discretionary Trading P&L

Holdings

Transaction History (81 total)

ONC
BeOne Medicines Ltd.
Aug 25, 2026
Sale(S)
Direct
280 shares at avg. $380.00$106K
ONC
BeOne Medicines Ltd.
Jun 23, 2026
Sale(S)
Direct
1.3K shares at avg. $276.26$357K
ONC
BeOne Medicines Ltd.
Jun 16, 2026
Sale(S)
Direct
1.4K shares at avg. $266.76$362K
ONC
BeOne Medicines Ltd.
Jun 11, 2026
Sale(S)
Direct
626 shares at avg. $261.20$164K
ONC
BeOne Medicines Ltd.
Jun 11, 2026
Award(A)
Direct
118.6K shares-
ONC
BeOne Medicines Ltd.
Jun 8, 2026
Sale(S)
Direct
1.4K shares at avg. $269.33$389K
ONC
BeOne Medicines Ltd.
Jun 8, 2026
Sale(S)
Direct
40 shares at avg. $270.55$11K
ONC
BeOne Medicines Ltd.
Mar 6, 2026
Award(A)
Direct
78.6K shares-
ONC
BeOne Medicines Ltd.
Mar 6, 2026
Award(A)
Direct
168.9K shares-
ONC
BeOne Medicines Ltd.
Nov 17, 2025
Sale(S)
Direct
826 shares at avg. $381.19$315K
ONC
BeOne Medicines Ltd.
Nov 17, 2025
Sale(S)
Direct
3.2K shares at avg. $380.23$1.2M
ONC
BeOne Medicines Ltd.
Nov 17, 2025
Sale(S)
Direct
10 shares at avg. $382.32$4K
ONC
BeOne Medicines Ltd.
Nov 13, 2025
Sale(S)
Direct
1.8K shares at avg. $381.05$674K
ONC
BeOne Medicines Ltd.
Nov 13, 2025
Sale(S)
Direct
4.2K shares at avg. $380.33$1.6M
ONC
BeOne Medicines Ltd.
Nov 12, 2025
Sale(S)
Direct
4.8K shares at avg. $360.10$1.7M
ONC
BeOne Medicines Ltd.
Nov 12, 2025
Sale(S)
Direct
789 shares at avg. $352.78$278K
ONC
BeOne Medicines Ltd.
Nov 12, 2025
Sale(S)
Direct
100 shares at avg. $357.43$36K
ONC
BeOne Medicines Ltd.
Nov 12, 2025
Sale(S)
Direct
120 shares at avg. $355.00$43K
ONC
BeOne Medicines Ltd.
Nov 12, 2025
Sale(S)
Direct
3.2K shares at avg. $351.41$1.1M
ONC
BeOne Medicines Ltd.
Nov 12, 2025
Sale(S)
Direct
251 shares at avg. $354.20$89K
ONC
BeOne Medicines Ltd.
Nov 12, 2025
Sale(S)
Direct
154 shares at avg. $362.07$56K
ONC
BeOne Medicines Ltd.
Nov 12, 2025
Sale(S)
Direct
500 shares at avg. $350.44$175K
ONC
BeOne Medicines Ltd.
Aug 14, 2025
Sale(S)
Direct
400 shares at avg. $300.86$120K
ONC
BeOne Medicines Ltd.
Aug 14, 2025
Sale(S)
Direct
5.8K shares at avg. $302.04$1.8M
ONC
BeOne Medicines Ltd.
Aug 14, 2025
Exercise(M)
Direct
9.2K shares at avg. $159.03$1.5M

		Type	Shares	Price		Ownership
Aug 25, 2026	ONC BeOne Medicines Ltd.	Sale(S)	280	$380.00	$106,400	Direct
Jun 23, 2026	ONC BeOne Medicines Ltd.	Sale(S)	1,292	$276.26	$356,927	Direct
Jun 16, 2026	ONC BeOne Medicines Ltd.	Sale(S)	1,357	$266.76	$361,997	Direct
Jun 11, 2026	ONC BeOne Medicines Ltd.	Sale(S)	626	$261.20	$163,512	Direct
Jun 11, 2026	ONC BeOne Medicines Ltd.	Award(A)	118,625	-	$0	Direct
Jun 8, 2026	ONC BeOne Medicines Ltd.	Sale(S)	1,444	$269.33	$388,916	Direct
Jun 8, 2026	ONC BeOne Medicines Ltd.	Sale(S)	40	$270.55	$10,822	Direct
Mar 6, 2026	ONC BeOne Medicines Ltd.	Award(A)	78,624	-	$0	Direct
Mar 6, 2026	ONC BeOne Medicines Ltd.	Award(A)	168,922	-	$0	Direct
Nov 17, 2025	ONC BeOne Medicines Ltd.	Sale(S)	826	$381.19	$314,862	Direct
Nov 17, 2025	ONC BeOne Medicines Ltd.	Sale(S)	3,155	$380.23	$1,199,617	Direct
Nov 17, 2025	ONC BeOne Medicines Ltd.	Sale(S)	10	$382.32	$3,823	Direct
Nov 13, 2025	ONC BeOne Medicines Ltd.	Sale(S)	1,769	$381.05	$674,077	Direct
Nov 13, 2025	ONC BeOne Medicines Ltd.	Sale(S)	4,240	$380.33	$1,612,583	Direct
Nov 12, 2025	ONC BeOne Medicines Ltd.	Sale(S)	4,846	$360.10	$1,745,024	Direct
Nov 12, 2025	ONC BeOne Medicines Ltd.	Sale(S)	789	$352.78	$278,341	Direct
Nov 12, 2025	ONC BeOne Medicines Ltd.	Sale(S)	100	$357.43	$35,743	Direct
Nov 12, 2025	ONC BeOne Medicines Ltd.	Sale(S)	120	$355.00	$42,600	Direct
Nov 12, 2025	ONC BeOne Medicines Ltd.	Sale(S)	3,240	$351.41	$1,138,569	Direct
Nov 12, 2025	ONC BeOne Medicines Ltd.	Sale(S)	251	$354.20	$88,903	Direct
Nov 12, 2025	ONC BeOne Medicines Ltd.	Sale(S)	154	$362.07	$55,759	Direct
Nov 12, 2025	ONC BeOne Medicines Ltd.	Sale(S)	500	$350.44	$175,221	Direct
Aug 14, 2025	ONC BeOne Medicines Ltd.	Sale(S)	400	$300.86	$120,345	Direct
Aug 14, 2025	ONC BeOne Medicines Ltd.	Sale(S)	5,800	$302.04	$1,751,857	Direct
Aug 14, 2025	ONC BeOne Medicines Ltd.	Exercise(M)	9,180	$159.03	$1,459,895	Direct

1-25 of 81 transactions

About Wu Xiaobin

Wu Xiaobin (SEC CIK 0001739452) files insider reports with the SEC as President and COO of BeOne Medicines Ltd. (ONC).

Signal8 holds 21 ownership filings by Wu Xiaobin, all Form 4s, filed between Sep 5, 2024 and Aug 27, 2026. Those filings report 81 transactions, from Sep 3, 2024 to Aug 25, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Wu Xiaobin's filings is in BASEL.

Recent filings by Wu Xiaobin

Aug 25, 2026: Open-market sale of ONC shares (Form 4, code S).
Jun 23, 2026: Open-market sale of ONC shares (Form 4, code S).
Jun 16, 2026: Open-market sale of ONC shares (Form 4, code S).
Jun 11, 2026: Open-market sale of ONC shares (Form 4, code S).
Jun 11, 2026: Grant or award of ONC shares (Form 4, code A).

Other insiders filing for BeOne Medicines Ltd. (ONC)

Wang Xiaodong, Director
Lee Chan Henry, SVP, General Counsel
Ball Titus B., Principal Accounting Officer
OYLER JOHN, Chief Executive Officer
Rosenberg Aaron, Chief Financial Officer
Wang Lai, President, Global Head of R&D

How to read Form 4 transaction codes